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Cultured neurons obtained from MAP1B-deﬁcient mice have a delay in axon outgrowth and a reduced rate of axonal
elongation compared with neurons from wild-type mice. Here we show that MAP1B deﬁciency results in a signiﬁcant
decrease in Rac1 and cdc42 activity and a signiﬁcant increase in Rho activity. We found that MAP1B interacted with
Tiam1, a guanosine nucleotide exchange factor for Rac1. The decrease in Rac1/cdc42 activity was paralleled by decreases
in the phosphorylation of the downstream effectors of these proteins, such as LIMK-1 and coﬁlin. The expression of a
constitutively active form of Rac1, cdc42, or Tiam1 rescued the axon growth defect of MAP1B-deﬁcient neurons. Taken
together, these observations deﬁne a new and crucial function of MAP1B that we show to be required for efﬁcient
cross-talk between microtubules and the actin cytoskeleton during neuronal polarization.
INTRODUCTION
Neurons are highly polarized cells that contain a single long
axon and several dendrites. Polarization occurs when one of
the multiple neurites emerging from the cell body initiates a
phase of rapid elongation, becoming an axon. Axon forma-
tion is causally related to dramatic changes in the organiza-
tion and dynamics of the growth cone cytoskeleton. These
changes involve an expansion of the peripheral lamellipo-
dial veil, a shortening of actin ribs, an increase in actin
dynamics, and the penetration of tyrosinated (presumably
dynamic) microtubules within the central growth cone re-
gion (Bradke and Dotti, 1997, 1999; Kunda et al., 2001). In the
presence of the actin-depolymerizing drug, cytochalasin D,
all minor processes can generate an axon. This treatment
leads to multiple axon formation, a phenomenon preceded
by the penetration of microtubules within neuritic tips de-
void of actin ﬁlaments (Bradke and Dotti, 1999; Ruthel and
Hollenbeck, 2000; Kunda et al., 2001). Therefore, if all neu-
rites have the potential to become an axon, what causes
cytoskeletal changes at one particular neuritic growth cone
so that this neurite but none of the others becomes the axon?
This process has been proposed to depend on a polarity
complex that includes microtubule-modifying proteins such
as crmp2 and molecules that regulate actin polymerization,
such as cdc42 (Inagaki et al., 2001; Nishimura et al., 2005;
Sosa et al., 2006). A reasonable hypothesis is that axon for-
mation takes place from the growth cone that has a more
dynamic microtubule polymer, which promotes lamellipo-
dial protrusion and expansion similar to what occurs in
migrating ﬁbroblasts (Waterman-Storer et al., 1999). More-
over, it has been also described the importance of local
microtubule stabilization to induce axon formation (Witte et
al., 2008).
To test this hypothesis, we have focused our attention on
the microtubule-associated protein MAP1B. There are sev-
eral reasons for this choice. MAP1B is the ﬁrst MAP that is
expressed and is especially prominent in developing neu-
rons, being highly concentrated at the distal tip of growing
axons where it associates with tyrosinated microtubules
(Black et al., 1994). Suppression of MAP1B with antisense
oligonucleotides inhibits laminin-enhanced axonal growth
(DiTella et al., 1996). Furthermore, targeted disruption of the
MAP1B gene results in an impairment of brain development
(Edelmann et al., 1996; Takei et al., 1997; Gonzalez-Billault et
al., 2000; Meixner et al., 2000; Takei et al., 2000), altering
processes that are dependent on the appearance of neuronal
cytoplasmic extensions such as neuronal migration (Gonza-
lez-Billault et al., 2005) and axonal guidance (Del Rio et al.,
2004). More importantly, cultured hippocampal pyramidal
neurons obtained from MAP1B-deﬁcient mice have a signif-
icant delay in axon outgrowth and a reduced rate of axonal
elongation (Takei et al., 2000; Gonzalez-Billault et al., 2001).
These neurons display growth cones with small lamelli-
podial veils, as well as decreased microtubule assembly
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3518and dynamics that are quite evident at the distal axonal
tip, where the more recently assembled microtubule poly-
mer normally predominates (Gonzalez-Billault et al., 2001).
MAP1B is not only a microtubule-associated protein but also
an actin-binding protein (Pedrotti and Islam, 1996; Cueille et
al., 2007). It has been proposed that MAP1B, apart from
being a microtubule-stabilizing protein, may also function as
a scaffold protein (Riederer, 2007). In this work, we show
that MAP1B participate in the regulation of the cross-talk




Cultures of dissociated hippocampal pyramidal cells from wild-type (WT)
and MAP1B knockout mouse embryonic brain tissue were prepared as de-
scribed (Gonzalez-Billault et al., 2001). All cultures were maintained in a
humidiﬁed 37°C incubator with 5% CO2. For some experiments, cytochalasin
D was added to the cultures at a concentration of 0.5 g/ml for 3, 6, and 12 h.
Expression Plasmids and Transfection
The following plasmids were used for transfection of primary cultures: 1)
Tiam1 cDNA (C1199; Kunda et al., 2001) cloned as a BamHI/XhoI fragment
into pcDNA3 containing a cytomegalovirus promoter and a hemagglutinin
tag; 2) cDNA for constitutively active Rac1 (CA-Rac1, V12 mutant) and
another for WT-Rac1 cloned in pcDNA3 containing a myc tag; and 3) A cDNA
for WT cdc42 and another for constitutively active cdc42 (V12 cdc42) cloned
in pcDNA3 containing a myc tag. Transient transfection of cultured neurons
was performed using the Amaxa mouse neuron nucleofector kit (Gaithers-
burg, MD). The neurons were nucleofected at 0 DIV (days in vitro), and all
cDNAs were used at concentrations of 3 g/ml. Cells were analyzed 24 h
after transfection.
Primary Antibodies
The following primary antibodies were used in this study: anti-tyrosinated
-tubulin mAb (clone TUB-1A2, mouse IgG, Sigma Chemical Co., St. Louis,
MO) diluted 1:2000; anti--tubulin mAb (Sigma) diluted 1:2000; a goat Ab
against MAP1B diluted 1:2000 (N-19, Santa Cruz Biotechnology, Santa Cruz,
CA); rabbit antibody against Tiam1 diluted 1:200 (Santa Cruz Biotechnology);
anti-hemagglutinin mAb diluted 1:1000; a mAb against myc diluted 1:500
(Santa Cruz Biotechnology); goat antibody against p-MYPT1 diluted 1:500
(Santa Cruz Biotechnology); anti-coﬁlin mAb diluted 1:1000, a generous gift of
Dr. James Bamburg (Colorado State University); rabbit antibody against
P-coﬁlin diluted 1:1000, a gift of Dr. Bamburg; goat antibody against Limk-1
(Santa Cruz Biotechnology) diluted 1:1000; rabbit antibody against P-Limk1
diluted 1.1000 (Cell Signaling, Beverly, MA), phalloidin-TRITC (Sigma) and
phalloidin-FITC (Molecular Probes, Eugene, OR) to label the actin cytoskele-
ton diluted 1:200. Antibodies against Rac1, Cdc42, and RhoA (Cytoskeleton,
Denver, CO) diluted 1:500.
Immunoﬂuorescence
Cells were ﬁxed before or after detergent extraction under microtubule-
stabilizing conditions and processed for immunoﬂuorescence as described
(Kunda et al., 2001). For some experiments, in order to visualize the associa-
tion of Rac1 with the growth cone cytoskeleton, cells were ﬁxed as described
by Nakata and Hirokawa (Nakata and Hirokawa, 1987; Paglini et al., 1998).
The antibody staining protocol was carried out as described (Kunda et al.,
2001). Cells were analyzed in a Zeiss LSM 410 confocal scanning microscope
or in an inverted microscope (Zeiss Axiovert 35M) equipped with epiﬂuores-
cence and differential interference contrast optics (Thornwood, NY). The
relative intensities of Rac1, Tiam1, and F-actin staining were evaluated in
ﬁxed unextracted cells or in detergent-extracted cytoskeletons using quanti-
tative ﬂuorescence techniques as described (Paglini et al., 1998). Images were
collected using a CCD camera (Orca 1000) and Metamorph software. To
measure axonal length, cells were analyzed with a Zeiss LSM 510 META
confocal scanning microscope.
Immunoprecipitation
The cortex and hippocampus of a mouse brain collected on embryonic day 18
(E18) were homogenized in 0.7 ml of cold immunoprecipitation buffer (1%
wt/vol Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM
EGTA, pH 8.0, 0.2 mM sodium orthovanadate, 0.2 mM phenylmethylsulfo-
nylﬂuoride [PMSF], and 0.5% wt/vol Nonidet P40). The homogenate was
centrifuged at 16,000  g for 15 min at 4°C, and the supernatant was collected
as the total cell lysate.
To 400 g of the supernatant, 5 g of a speciﬁc antibody was added in a
ﬁnal volume of 1 ml. The solution was mixed with a vortex and incubated for
another1ha t4°C. Then 20 l of 50% protein A-agarose bead solution was
added, mixed, and incubated with agitation for 30 min at 4°C. The beads were
pelleted by centrifugation at 16,000  g for 15 min at 4°C, and the supernatant
was removed. The pellet was washed twice with immunoprecipitation buffer
and resuspended in 30 l of twofold-concentrated electrophoresis sample
buffer (250 mM Tris, pH 6.8, 4% [wt/vol] SDS, 10% glycerol, 0.006% bromo-
phenol blue, and 2% [wt/vol] 2-mercaptoethanol). The proteins were sepa-
rated by gel electrophoresis, and the fractionated proteins were then charac-
terized by Western blot analysis.
Rho-GTPase Activity Assays and Western Blotting
The Rac1 activity assay was done essentially as described (Waterman-Storer
et al., 1999). Brieﬂy, cultures of hippocampal pyramidal neurons (1 DIV) were
lysed at 4°C in 50 mM Tris, 150 mM NaCl, 1% Triton X-100, and 0.5%
deoxycholate, pH 7.2. GTP-bound Rac1 was afﬁnity-precipitated from cell
lysates at 4°C by using an immobilized GST fusion of the Rac1-binding
domain of murine PAK, which binds Rac1-GTP but not Rac1-GDP. Bound
proteins were separated by 12% SDS-PAGE and Western-blotted with anti-
Rac1 (Rac1 activation assay Biochem kit; Cytoskeleton). Pulldown assays of
activated cdc42 were carried out as described for Rac1, but were probed with
an antibody against cdc42 (Cytoskeleton,). Pulldown assays and western
blotting for activated RhoA were performed as described for Rac1, but using
an immobilized GST fusion of the Rho binding domain of the Rho effector
protein, rhotekin. The Rho binding domain motif has been shown to bind
speciﬁcally to the GTP-bound form of RhoA. Total RhoA and RhoA-GTP were
detected with mouse anti-RhoA mAbs (RhoA activation assay; Biochem kit;
Cytoskeleton).
Protein Extracts and Western Blots
Protein extracts were prepared from hippocampal pyramidal neuron cultures
and from the cortex and hippocampus of an embryonic mouse brain (E18) in
20 mM HEPES, pH 7.4, containing 0.1 mM NaCl, 10 mM NaF, 1 mM Na3VO4,
5 mM EDTA, 1 mM okadaic acid, and protease inhibitors (2 mM PMSF, 10
mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml pepstatin). Protein samples
were separated by SDS-PAGE, electroblotted onto nitrocellulose sheets, de-
veloped with an ECL chemiluminescence system, and quantiﬁed by densi-
tometry.
Morphometric Analysis of Neuronal Shape Parameters
Images were digitized on a video monitor using Metamorph software (Uni-
versal Imaging, West Chester, PA). To measure neurite length or growth cone
shape parameters, antibody-labeled cells were randomly selected and traced
from a video screen using the morphometric menu of Metamorph software as
described (Paglini et al., 1998; Kunda et al., 2001). Axonal lengths were
measured using the ImageJ program (http://rsb.info.nih.gov/ij/). Differ-
ences among groups were analyzed using ANOVA and the Student-New-
man-Keuls test.
RESULTS
The Delay in Axonal Development in Map1B/ Neurons
Is Related to a Defect in the Actin Cytoskeleton
To investigate whether MAP1B promotes axon formation by
regulating growth cone lamellipodial expansion and hence
actin dynamics, we ﬁrst analyzed the response of MAP1B-
deﬁcient (/) neurons to treatment with cytochalasin D,
an inhibitor of actin polymerization. Our aim was to deter-
mine whether the inhibition of axon formation observed in
MAP1B-deﬁcient neurons was primarily related to de-
creased microtubule assembly, as originally postulated
(Gonzalez-Billault et al., 2001), or to a failure to induce a
highly dynamic actin cytoskeleton permissive for microtu-
bule assembly, invasion, and subsequent growth. Figure 1,
A and B, are representative confocal images of pyramidal
neurons from MAP1B/ and MAP1B/ mice, respec-
tively, treated with antibodies against -tubulin (green) and
rhodamine-phalloidin (red). Brieﬂy, MAP1B-deﬁcient neu-
rons displayed shorter axons when compared with control
neurons, consistent with previously reported results
(Gonzalez-Billault et al., 2001). To analyze the role of local
actin polymerization, we treated control and MA1B/
cells with cytochalasin D. As reported (Bradke and Dotti,
1999), WT cultured hippocampal pyramidal neurons treated
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multiple long axon-like neurites (Figure 1C). Interestingly,
an identical phenomenon was observed in MAP1B-deﬁcient
neurons (Figure 1D). Double immunoﬂuorescence visualiza-
tion of cytochalasin D–treated MAP1B/ neurons with
antibodies against tyrosinated (Tyr-tub) and detyrosinated
(Glu-tub) -tubulin clearly revealed the presence of many
dynamic microtubules at neuritic tips (Figure 1F). Quantita-
tive ﬂuorescence measurements revealed that cytochalasin
D increased the Tyr-tubulin staining of axon-like neurites,
an effect that selectively occurred at the distal end of grow-
ing processes. Furthermore, in the presence of cytochalasin
Figure 1. Cytochalasin D restores the kinetics of axon development in MAP1B-deﬁcient cells. Cytochalasin D induced multiple axon
formation and promoted microtubule assembly in MAP1B-deﬁcient neurons. (A) Morphology and distribution of -tubulin (red) and
rhodamine-phalloidin (green) in WT hippocampal pyramidal neurons and in MAP1B-deﬁcient neurons. (B) Whereas WT-neurons extended
a single long axon under control conditions (A), MAP1B-deﬁcient neurons failed to do so. However, both WT and MAP1B-deﬁcient neurons
were capable of extending multiple axon-like neurites after treatment with cytochalasin D (0.5 g/ml). (C and D) Morphology of WT neurons
and MAP1B/ neurons, respectively, after6ho ftreatment with cytochalasin D, shown as a red (Glu-tubulin) and green (Tyr-tubulin)
overlay. (E) Morphology of the growth cone from a WT neuron in the absence of cytochalasin D shown as a red (F-actin) and green
(Tyr-tubulin) overlay. (F) Same conditions as in E after3ho ftreatment of WT neurons with cytochalasin D. The treatment induced the
penetration of Tyr-microtubules within areas devoid of actin ﬁlaments. Note that microtubules reach the outer rim of the ﬂattened neuritic
tip. (G) Graph showing the number of neurites extending for more than 40 m in untreated or cytochalasin D–treated neuronal cultures
obtained from WT (/) or MAP1B-deﬁcient (/) neurons. (H) Quantitative ﬂuorescent measurements of tyrosinated tubulin immuno-
labeling in cytoskeletal preparations from untreated and cytochalasin D–treated hippocampal pyramidal neurons of WT and MAP1B-
deﬁcient neurons. Measurements were performed in the initial segment (IS), external segment (ES), and growth cone (GC) of axons of WT
neurons or of the longest neurite of untreated MAP1B-deﬁcient neurons. In the case of cytochalasin D–treated neurons, measurements were
performed in all neurites extending more than 80 m. A total of 50 cells were analyzed for each experimental condition. Cells were treated
with cytochalasin D (0.5 g/ml) for 12 h. All cultures were ﬁxed for 36 h after plating. Bar, 10 m.
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tween WT and MAP1B-deﬁcient neurons (Figure 1G). Taken
together, these results demonstrate that after cytochalasin D
treatment, MAP1B-deﬁcient neurons were not only able to
generate axon-like neurites but also as capable as WT neu-
rons at assembling microtubules. Theses results suggest that
there was not a general defect in cytoskeleton components in
MAP1B/ mice but rather a defect in the regulation of the
assembly of their components.
MAP1B Deﬁciency Modiﬁes Activities of the
Rho-GTPases Rac1 and Cdc42
It follows that one primary function of MAP1B during initial
axon outgrowth may also be related to the regulation of
actin organization and the promotion of microtubule assem-
bly. To test this possibility, we examined whether MAP1B
deﬁciency altered the levels and/or activity of Rac1 or
cdc42. Rac1 and cdc42 are two small Rho-GTPases that are
involved in lamellipodial and ﬁlopodial expansion/protru-
sion, respectively (Bishop and Hall, 2000) and are required
for axon outgrowth, elongation, and branching (Luo, 2000,
2002; Ng et al., 2002). These proteins act as a molecular
switch cycling between an active GTP-bound and inactive
GDP-bound state. First, we determined that Rac1 was highly
expressed in growth cones of embryonic brain tissue (data
not shown). Next, to determine whether MAP1B was in-
volved in the regulation of Rac1 activity, we measured the
amount of GTP-bound Rac1 in cultured neurons derived
from WT and MAP1B-deﬁcient mice after 1 DIV. To measure
Rac1 activity, we used a glutathione S-transferase (GST)
fusion protein corresponding to the p21-binding domain
(residues 67–150) of murine PAK1, a Rac effector that binds
with high-afﬁnity to Rac1-GTP but not Rac1-GDP in a pull-
down assay. We found that cell extracts from MAP1B-deﬁ-
cient mice had signiﬁcantly lower Rac1 activity than extracts
from WT mice (Figure 2A). Total Rac1 protein levels were
similar in MAP1B-deﬁcient neuron extracts and control sam-
ples (Figure 2A). Quantitative analyses showed that there
was a 90% decrease in Rac1 activity in MAP1B-deﬁcienct
neurons compared with control neurons (Figure 2A, right).
Next, we analyzed whether the overexpression of CA-Rac or
WT-Rac could induce axon formation in MAP1B/ neu-
rons. Overexpression of CA-Rac1 in transfected MAP1B-deﬁ-
cient neurons resulted in extensions that resembled axon-like
neurites (Figure 2, B and D). These neurites displayed growth
cones with prominent lamellipodial veils, as well as growth
cone-like structures located along the main axonal shaft, which
are two features of rapidly growing axons (Bradke and Dotti,
1999; Ruthel and Banker, 1999). In contrast, overexpression of
WT-Rac1 in transfected MAP1B-deﬁcient neurons had no effect
on promoting axon extension (Figure 2, B and C). Quantitative
analyses revealed that the MAP1B-deﬁcient neurons trans-
Figure 2. MAP1B deﬁciency decreases Rac1 activity. (A) Western blot showing that neuron culture extracts obtained from the embryonic
hippocampus of WT (/) mice contain considerably more Rac1-GTP than equivalent samples obtained from MAP1B-deﬁcient (/)
animals. Total Rac1 and -actin were used as loading control. Quantitative analysis conﬁrmed a signiﬁcant decrease (*p  0.05) in Rac1
activity in MAP1B-deﬁcient cells. (B) Morphology of a hippocampal MAP1B (/) neuron as shown by confocal microscopy (a). The cell
displays one single long axon and was stained with an antibody against -tubulin (red). Morphology of a hippocampal MAP1B (/)
neuron as shown by confocal microscopy (b). The cell displays a very short axon-like neurite and was stained as in panel a. The short
axon-like neurite in a MAP1B (/) neuron transfected with Rac1-WT resembles neurites in MAP1B (/) neurons. Morphology of a
MAP1B-deﬁcient neuron transfected with myc-tagged constitutively active Rac1 (CA-Rac1) after plating and then ﬁxing 24 h later; cells were
visualized by confocal microscopy. Cells were stained with an antibody against c-myc. Note that the cell displays a long axon-like neurite
and several much shorter minor neurites. Bars, 10 m. (C) Quantitative analyses indicated that MAP1B-deﬁcient neurons transfected with
CA-Rac1 displayed axons with a length similar to WT neurons (*p  0.05). (D) Quantitative ﬂuorescence measurements of Rac1 and
phalloidin immunolabeling in cytoskeletal preparations from WT (/) and MAP1B-deﬁcient (/) cultured hippocampal pyramidal
neurons. Measurements were performed within a 10-m area located at the periphery of growth cones of minor processes and axons.
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of WT neurons (Figure 2C).
Because activated Rac1 binds to membranes, we used
high-resolution ﬂuorescence microscopy and quantitative
ﬂuorescence to analyze its subcellular distribution in deter-
gent-extracted cytoskeletal fractions prepared under condi-
tions that stabilize cytoskeletal-membrane interactions (Na-
kata and Hirokawa, 1987). In WT neurons, the highest
immunoﬂuorescence signals for Rac1 were detected in the
peripheral lamellipodial veil of axonal growth cones and in
the largest unpolarized neurons. Lower immunoﬂuores-
cence signals were detected in the growth cones of the
remaining minor processes (Figure 2D). The intensities of
these signals were equivalent to those observed in the
growth cones of MAP1B-deﬁcient neurons, either displaying
only minor processes or minor processes plus a short axon.
We performed a similar analysis to test whether cdc42
activation was also affected in MAP1B-deﬁcient neurons.
Figure 3. MAP1B deﬁciency decreases cdc42 activity. (A) Western blot showing that neuron culture extracts obtained from the embryonic
hippocampus of WT (/) mice contain more cdc42-GTP than equivalent samples obtained from MAP1B-deﬁcient (/) animals. Total
cdc42 and -actin were used as loading controls. Quantitative analysis conﬁrmed a signiﬁcant decrease (*p  0.05) in cdc42 activity in
MAP1B-deﬁcient cells. (B) Morphology of a MAP1B-deﬁcient (/) neuron transfected with myc-tagged WT-cdc42 after plating and ﬁxing
24 h later, as visualized by confocal microscopy. Cells were stained with an antibody against c-myc. Note that the cell displays a short
axon-like neurite similar to those seen in MAP1B-deﬁcient neurons. Bar, 10 m. (C) Morphology of a MAP1B (/) neuron transfected with
myc-tagged constitutively active cdc42 (CA-cdc42). Cells were stained as in B. Note that the cell displays a long single axon-like neurite
(arrow). Bar, 10 m. (D) Quantitative analyses indicated that MAP1B-deﬁcient neurons transfected with CA-cdc42 had axons of length similar
to WT (/). *p  0.05.
Figure 4. MAP1B deﬁciency induces changes
in the amount of activated proteins down-
stream of Rac1. (A) Western blots showed di-
minished levels of phosphorylated LIMK in
brain extracts derived from MAP1B (/)
mice compared with WT (/) littermates.
Quantitative analyses of the ratio between
phosphorylated and nonphosphorylated LIMK
are indicated. *p  0.05. (B) Western blots
showing decreased levels of phosphorylated
coﬁlin in brain extracts derived from MAP1B
(/) mice compared with WT (/) litter-
mates. Quantitative analyses indicated the ratio
between phosphorylated and nonphosphory-
lated coﬁlin was signiﬁcant; p  0.05. (C) Sche-
matic showing the downstream effectors of
Rac1.
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proper Rac1 activation in neuronal cells (Nishimura et al.,
2005). As expected, there was a 50% decrease in cdc42 ac-
tivity in MAP1B-deﬁcient cells compared with control cells
(Figure 3A). These changes were independent of the overall
amount of cdc42 (Figure 3A). We also determined that over-
expression of CA-cdc42 in MAP1B/ neurons induced axon
formation (Figure 3C), whereas overexpression of WT-cdc42
had no signiﬁcant effect (Figure 3B). Quantitative analyses
showed that overexpression of CA-cdc42 in MAP1B/ cells
induced formation of axons with lengths similar to those of WT
neurons (Figure 3D).
Decreased Phosphorylation of LIMK-1 and Coﬁlin in
MAP1B-deﬁcient Neurons
The signaling cascade downstream of Rac1 and cdc42 acti-
vation involves the activation of the serine/threonine pro-
tein kinase LIMK-1 (Arber et al., 1998; Yang et al., 1998).
LIMK-1, a downstream effector of Rac1 activity, phosphor-
ylates the actin-binding protein coﬁlin (Yang et al., 1998).
Transitions between the phosphorylated and dephosphory-
lated forms of coﬁlin are responsible for changes in the
content of actin microﬁlaments (Bamburg and Bray, 1987;
Bamburg, 1999; Sarmiere and Bamburg, 2004). Therefore, we
Figure 5. MAP1B deﬁciency increases RhoA
activity. (A) Western blot showing that neuron
culture extracts obtained from the embryonic
hippocampus of WT (/) mice contain con-
siderably less RhoA-GTP than equivalent sam-
ples obtained from MAP1B-deﬁcient (/) an-
imals. Total RhoA and -actin were used as
loading controls. Quantitative analysis con-
ﬁrmed signiﬁcantly increased RhoA activity in
MAP1B-deﬁcient cells (p  0.05). (B) Western
blot showing that brain extracts derived from
WT (/) mice had increased phosphorylation
of MYPT1 (p-MYPT1) compared with equiva-
lent samples obtained from MAP1B-deﬁcient
animals (/). Quantitative analyses con-
ﬁrmed signiﬁcantly increased phosphorylation
of MYPT1 (p  0.05). (C) Schematic showing
the RhoA pathway in which MYPT1 is in-
volved.
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with changes in the activation of LIMK-1 and coﬁlin. Phos-
phorylated LIMK-1 was diminished in protein extracts de-
rived from MAP1B-deﬁcient neurons compared with WT
neurons (Figure 4A). The ratio of phospho-LIMK-1 to total
LIMK-1 was also signiﬁcantly decreased in MAP1B-deﬁcient
neurons (Figure 4A, right). We then analyzed phosphory-
lated coﬁlin levels in protein extracts derived from MAP1B-
deﬁcient neurons. Similarly to LIMK-1, phosphorylated coﬁlin
was also decreased in MAP1B-deﬁcient neurons compared
with WT neurons (Figure 4B). These results reinforce the hy-
pothesis that MAP1B loss-of-function leads to decreased Rac1
activity and subsequently affects the signaling cascade that
controls actin polymerization. Figure 4C shows one of the
signaling cascades downstream of Rac1 activation.
Increased RhoA Activity in MAP1B-deﬁcient Neurons
RhoA is a GTPase involved in neurite collapse (Bishop and
Hall, 2000), and it has been suggested that Rac1 activation
may result in decreased RhoA activity (Da Silva et al., 2003;
Ik-Tsen Heng et al., 2009). To test whether the decrease in
Rac1 activity observed in MAP1B-deﬁcient neurons could
result in increased RhoA activity, we analyzed effects of
MAP1B deﬁciency on RhoA activation. RhoA activity in
MAP1B-deﬁcient neurons was increased compared with
control WT neurons (Figure 5A). This change was not due to
increased RhoA expression because the overall levels of
RhoA were similar in WT and MAP1B-deﬁcient neurons
(Figure 5A). Quantitative analyses indicated a dramatic 80%
increase in RhoA activation in MAP1B-deﬁcient cells (Figure
5A, right). The canonical signaling pathway downstream of
RhoA includes activation of the serine/threonine kinase
RhoK (Maekawa et al., 1999). Therefore, we assessed the
effects of MAP1B deﬁciency on phosphorylation of MYPT1, a
speciﬁc substrate for Rho-kinase. Consistently, there was a
signiﬁcant increase in the amount of phospho-MYPT1 in neu-
rons derived from MAP1B-deﬁcient mice compared with WT
mice (Figure 5B). Increased phospho-MYPT1 would result in
an increased growth cone collapse. Figure 5C shows the RhoA
signaling pathway where MYPT1 is involved.
Reduced Interaction of Tiam1 with Rac1 in
MAP1B-deﬁcient Neurons
Having shown that MAP1B deﬁciency was associated
with decreased Rac1 activity, we sought to determine the
molecular mechanism implicated in Rac1 inactivation.
The invasion-inducing T-lymphoma and metastasis 1 pro-
tein (Tiam1) functions as a guanine nucleotide exchange
factor (GEF) for Rac1 stimulating Rac1 activity (Figure 6A).
Tiam1 behaves as a microtubule-associated protein in brain
tissues, and it interacts with dynamic microtubules of the
axonal growth cone and promotes axon formation in cul-
tured hippocampal neurons (Kunda et al., 2001). We ﬁrst
analyzed the distribution of Tiam1 in WT and MAP1B/
neurons. In WT neurons, Tiam1 was mainly found at the
distal end of axons including the growth cones (Figure 6B).
In MAP1B-deﬁcient neurons, most of the staining was lo-
cated in the cell body (Figure 6C). Because Tiam1 is a GEF
for Rac1, we decided to measure the amount of Tiam1
bound to Rac1-GTP in our pulldown assay. We found a
dramatic decrease of Tiam1 bound to Rac-GTP in MAP1B-
deﬁcient neurons compared with WT (Figure 6F). This
change was not dependent on the level of Tiam1 expression
because the amounts of Tiam1 and Rac1 in hippocampal cell
lysates were similar in WT control and MAP1B-deﬁcient
cells (Figure 6F). Quantitative analyses indicated that
Tiam1–Rac1–GTP complex formation in MAP1B-deﬁcient
neurons was decreased by 70% compared with WT controls
(Figure 6F, right).
We then sought to determine whether it was possible to
induce axon formation in MAP1B-deﬁcient neurons by over-
expressing a Tiam1 variant that localizes to the plasma
membrane and is constitutively active (CA-Tiam1; clone
Figure 6. MAP1B deﬁciency alters Tiam1 distribution and its bind-
ing to Rac1. (A) Schematic showing that an external signal activates
Tiam1, which facilitates GDP for GTP exchange on Rac1, thereby
activating Rac1. (B and C) Representative confocal images from
hippocampal WT MAP1B (/) and MAP1B-deﬁcient (/) neu-
rons, respectively. The cells were stained with anti-Tiam1 (green).
Note that the distribution of Tiam1 in MAP1B (/) neurons was
predominantly in the axon and less in soma. In contrast the distri-
bution in MAP1B/ was predominantly in the soma. Bar, 10 m.
(D and E) Fluorescence images shown the morphology of WT
MAP1B (/) and MAP1B (/), respectively, inmunostaining
with -tubulin (red). (F) Decreased Tiam1–Rac1 interactions in pull-
down assays using supernatants derived from MAP1B-deﬁcient
neurons (/). These changes were not due to changes in the
expression of either Rac1 or Tiam1. -Actin was used as a loading
control. Quantitative analysis conﬁrmed a signiﬁcant decrease in
Tiam1–Rac1 interactions in MAP1B-deﬁcient neurons (*p  0.05).
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the axon growth defect in MAP1B-deﬁcient neurons (Figure
7, A and B). Reversal of the axonal elongation defect in
MAP1B/ neurons via overexpression of CA-Tiam1 was
statistically signiﬁcant (Figure 7C).
Tiam1 Interacts with MAP1B
Finally, we tested whether MAP1B binds to Tiam1. Such
binding could explain the delay in axon elongation in
MAP1B/ neurons as a consequence of decreased activity
of the Rho GTPases Rac1 and cdc42. Fluorescence micros-
copy using anti-MAP1B and anti-Tiam1 showed that Tiam1
and MAP1B colocalized mainly in axons of developing neu-
rons (Figure 8, A–D). These results were conﬁrmed in coim-
munoprecipitation assays, in which an antiserum to MAP1B,
but not the preimmune serum, was capable of coimmuno-
precipitating Tiam1. Furthermore, reciprocal coimmunopre-
cipitation showed that an antiserum to Tiam1 was capable of
Figure 7. Tiam1 overexpression can rescue the kinetics of axonal elongation in MAP1B-deﬁcient neurons. (A and B) Confocal micrographs
showing the morphology of a MAP1B-deﬁcient neuron (/) transfected with C1199 (CA-Tiam1), a constitutively active variant that can
efﬁciently activate Rac1. The neurons were transfected after plating and then were ﬁxed 24 h later and stained with anti-Tiam1 and a mAb
against tyrosinated -tubulin. Note that the cell developed a single long axon-like neurite (arrow in each panel). Bar, 10 m. (C) Quantitative
analyses indicated that the MAP1B-deﬁcient neurons transfected with CA-Tiam1 displayed axons with a length similar to WT (/) neurons
(*p  0.05).
Figure 8. Tiam1 interacts with MAP1B. (A–D) Confocal images from a WT MAP1B neuron stained for Tiam1 (green, A), MAP1B (red, B),
or Tau1 (blue, C). (D) A merge of images in A–C. Note that this protein colocalized mainly in the axon (arrow in each panel). Bar in D, 10
m. (E) Coimmunoprecipitation (IP) of Tiam1 and MAP1B from brain extracts obtained from embryonic mouse cortex (Cx) and hippocampus
(Hp). Antibodies against Tiam1 or MAP1B were used to visualize these proteins in Western blots (WB).
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gest that MAP1B binds to Tiam1 and plays a role in regulating
Rac1, which is required to induce axonal elongation.
DISCUSSION
Reorganization of the growth cone cytoskeleton involves
lamellipodial expansion and protrusion, Rac1/cdc42 activa-
tion, and microtubule growth and invasion. This reorgani-
zation is essential for axon formation (Bradke and Dotti,
1999; Kunda et al., 2001). It has been shown that localized
activation of Rac1-GTPase contributes to the rapid elonga-
tion of the nascent axon (Kunda et al., 2001). In this context,
it has been reported that the Par3/Par6 complex of polarity
may activate Rac1 by recruiting Tiam1, a Rac1-speciﬁc GEF.
This recruitment may also depend on cdc42 activation
(Nishimura et al., 2005). Interestingly, signaling molecules
located downstream of cdc42/Rac1 are also implicated in
axonal elongation. Thus, neurons derived from cdc42-null
mutant mice display decreased axonal elongation (Garvalov
et al., 2007). In this genetic model, coﬁlin phosphorylation
levels are also altered (Garvalov et al., 2007).
Here we present evidence that the microtubule-associated
protein MAP1B participate in the regulation of the cross-talk
between microtubules and actin microﬁlaments to promote
axonal elongation. Our evidence shows that MAP1B de-
ﬁciency produced a decrease in the activitys of the Rho-
GTPases Rac1/cdc42 and an increase in RhoA activity.
These results support many studies that indicate that mem-
bers of the Rho family of small GTPases, including Rho,
Rac1, and cdc42, seem to be the major players in regulating
the cross-talk between actin and microtubules in developing
neurons, for axon speciﬁcation, guidance and elongation
(Wittmann and Waterman-Storer, 2001). Moreover, during
cell polarization, there is evidence of cross-talk between
actin and microtubules via the small GTPase Rho. For ex-
ample, IQGAP1, an effector of Rac1 and cdc42, interacts with
CLIP-170, a protein that binds to the growing ends of mi-
crotubules (Fukata et al., 2002). PAK, another effector of
Rac1 and cdc42, phosphorylates stathmin, which binds to
microtubules and is able to destabilize them (Daub et al.,
2001; Wittmann et al., 2004). mDia is another protein that is
implicated in this cross-talk between microtubules and actin,
via Rho (Kodama et al., 2003). Together these data indicate
Figure 9. Schematic illustrating a potential
mechanism to explain why MAP1B is neces-
sary for Tiam1 activity. In the presence of
MAP1B, Tiam1 is able to bind to microtu-
bules. This binding appears to be required for
efﬁcient activation of cdc42 and Rac1. Activa-
tion of the Rac1 pathway results in the inhi-
bition of coﬁlin, which permits actin polymer-
ization and subsequent axon development.
Moreover, Rac1 inhibits the RhoA pathway,
thereby avoiding growth cone collapse. In the
absence of MAP1B, Tiam1 is localized in the
cytoplasm and does not activate the Rac1
pathway. Inhibition of the Rac1 pathway
leads to activation of the RhoA pathway and
growth cone collapse.
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play a role in regulating cross-talk between actin and micro-
tubules during axonal elongation.
Our results provide evidence that MAP1B-containing mi-
crotubules act as regulators of Rac1 activity during axon
outgrowth through interactions with Tiam1 (Figure 9). Our
results clearly indicate that MAP1B serves as a “ﬂag” to
target Tiam1 to a particular microtubule subset (e.g., Tyr-
containing microtubules; Kunda et al., 2001). This targeting
contributes to the spatiotemporal activation of Rac1. Rac1
activation may not be only dependent on Tiam1 function,
because it had been reported other GEFs contributing to
neuronal polarity. Among them is DOCK7, which regulates
neuronal polarity, and contribute to regulate the local phos-
phorylation of Stathmin/Op18 (Watabe-Uchida et al., 2006).
It follows, we cannot rule out the participation of this and
other GEFs in our model. However in this work we focused
on the study of Tiam1 for several reasons: 1) Tiam1 is
expressed at high levels in the developing brain; 2)There is
a high degree of temporal correlation between its expression
and the morphological development of the axon; 3) Tiam1
protein levels peak 24 h after plating just at the time in which
axon formation begins; and 4) Immunoﬂuorescence studies
show that in stage 3 neurons Tiam1 preferentially localizes
to axonal shafts and their growth cones and ﬁnally and the
most relevant point is that Tiam1 associates with microtu-
bules (Kunda et al., 2001). This point makes it an attractive
candidate to interact with an MAP, such as MAP1B. Impor-
tantly, our data are consistent with previous reports that
indicate an interaction between STEF (a homolog of Tiam1)
and a subunit of MAP1B (Takefuji et al., 2007). Interestingly,
the STEF1-LC1 interaction is inhibited due to Rho-kinase–
dependent phosphorylation of STEF1. In our study, Rho-
kinase was activated in MAP1B-deﬁcient cells, as indicated
by our pulldown assays. Moreover, there was an increase in
the phosphorylation of the myosin phosphatase target sub-
unit 1 (MYPT1), the myosin-binding subunit of myosin
phosphatase. Myosin phosphatase regulates the interaction
of actin and myosin downstream of RhoA, which inhibits
myosin phosphatase through the activation of Rho kinase.
This inhibition would ultimately cause shrinkage of the axon
and growth cone collapse. In addition, it has been shown
that Rac1-dependent inhibition of RhoA signaling induces
F-actin destabilization and promotes axonogenesis (Da Silva
et al., 2003; Sander et al., 1999). Based on the results pre-
sented here and the literature, our model proposes that
RhoA activation may depend on Rac1 inactivation. This
model would explain the delay in axon outgrowth and the
reduced rate of axonal elongation in MAP1B-deﬁcient neu-
rons. Additionally, the GEFs GEF-H1 and the Dbl-related
protein, Lfc, which are speciﬁc for Rho and Rac1 interact
with microtubules (Krendel et al., 2002).
Interestingly, microtubules at the distal end of the axon,
including the central and peripheral regions of the growth
cone, were enriched in both MAP1B and Tiam1. In contrast,
GTPase activation, as well as distal targeting of Tiam1, was
absent in neurons lacking MAP1B. Thus, MAP1B deﬁciency
was associated with increased Tiam1 localization in the cell
body. The present observations raise the possibility that
microtubules also regulate Rho-GTPase activity in develop-
ing neurons, similarly to such regulation in migrating ﬁbro-
blasts.
On the other hand, it has been shown that MAP1B deﬁ-
ciency induces a dramatic decrease in the content of tyrosi-
nated microtubules (Gonzalez-Billault et al., 2001). Tubulin
tyrosine ligase interacts with MAP1B in neuronal cells,
suggesting that loss of this interaction may be in part
responsible for decreased tyrosinated microtubules in
MAP1B-deﬁcient neurons (Utreras et al., 2008). Posttransla-
tional modiﬁcations of -tubulin are needed for axon spec-
iﬁcation as indicated by studies showing increased acetyla-
tion of -tubulin during axon initiation (Witte et al., 2008).
Moreover, these modiﬁcations (e.g., detyrosination of -tu-
bulin) also affected the binding of Tiam1 to microtubules.
In any case, the present observations raise the possibility
that, in developing neurons, microtubules regulate Rho-
GTPase activity, as proposed for migrating ﬁbroblasts. Fur-
thermore, regardless of the mechanism, the requirement of
MAP1B for effective binding of Tiam1 to microtubules ap-
pears to deﬁne a new and crucial function for this MAP
during neuronal polarization.
ACKNOWLEDGMENTS
This work was supported by FONDECYT (PICT 05-01697) and grants from
FONCyT (PICT 815), Agencia Cordoba Ciencia, and HHMI to A.C. J.A. was
supported by a Plan National Grant (SAF 2006-02424), CIBERNED and Co-
munidad de Madrid (SAL 0202-2006). C.G.-B. was supported by Fondecyt
1095089 and ICM P05-001-F.
REFERENCES
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A.,
Bernard, O., and Caroni, P. (1998). Regulation of actin dynamics through
phosphorylation of coﬁlin by LIM-kinase. Nature 393, 805–809.
Bamburg, J. R. (1999). Proteins of the ADF/coﬁlin family: essential regulators
of actin dynamics. Annu. Rev. Cell Dev. Biol. 15, 185–230.
Bamburg, J. R., and Bray, D. (1987). Distribution and cellular localization of
actin depolymerizing factor. J. Cell Biol. 105, 2817–2825.
Bishop, A. L., and Hall, A. (2000). Rho GTPases and their effector proteins.
Biochem. J. 348(Pt 2), 241–255.
Black, M. M., Slaughter, T., and Fischer, I. (1994). Microtubule-associated
protein 1b (MAP1b) is concentrated in the distal region of growing axons.
J. Neurosci. 14, 857–870.
Bradke, F., and Dotti, C. G. (1997). Neuronal polarity: vectorial cytoplasmic
ﬂow precedes axon formation. Neuron 19, 1175–1186.
Bradke, F., and Dotti, C. G. (1999). The role of local actin instability in axon
formation. Science 283, 1931–1934.
Cueille, N., Blanc, C. T., Popa-Nita, S., Kasas, S., Catsicas, S., Dietler, G., and
Riederer, B. M. (2007). Characterization of MAP1B heavy chain interaction
with actin. Brain Res. Bull. 71, 610–618.
Da Silva, J. S., Medina, M., Zuliani, C., Di Nardo, A., Witke, W., and Dotti,
C. G. (2003). RhoA/ROCK regulation of neuritogenesis via proﬁlin IIa-medi-
ated control of actin stability. J. Cell Biol. 162, 1267–1279.
Daub, H., Gevaert, K., Vandekerckhove, J., Sobel, A., Hall, A. (2001). Rac/
cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin
through phosphorylation at serine 16. J. Biol. Chem. 276, 1677–1680.
Del Rio, J. A., et al. (2004). MAP1B is required for Netrin 1 signaling in
neuronal migration and axonal guidance. Curr. Biol. 14, 840–850.
DiTella, M. C., Feiguin, F., Carri, N., Kosik, K. S., and Caceres, A. (1996).
MAP-1B/TAU functional redundancy during laminin-enhanced axonal
growth. J. Cell Sci. 109(Pt 2), 467–477.
Edelmann, W., Zervas, M., Costello, P., Roback, L., Fischer, I., Hammarback,
J. A., Cowan, N., Davies, P., Wainer, B., and Kucherlapati, R. (1996). Neuronal
abnormalities in microtubule-associated protein 1B mutant mice. Proc. Natl.
Acad. Sci. USA 93, 1270–1275.
Fukata, M., Watanabe T., Noritake J., Nakagawa M., Yamaga M., Kuroda S.,
Matsuura Y., Iwamatsu A., Perez F., and Kaibuchi K. (2002) Rac1 and Cdc42
capture microtubules through IQGAP1 and CLIP-170. Cell 109, 873–885.
Garvalov, B. K., Flynn, K. C., Neukirchen, D., Meyn, L., Teusch, N., Wu, X.,
Brakebusch, C., Bamburg, J. R., and Bradke, F. (2007). Cdc42 regulates coﬁlin
during the establishment of neuronal polarity. J. Neurosci. 27, 13117–13129.
Gonzalez-Billault, C., Avila, J., and Caceres, A. (2001). Evidence for the role of
MAP1B in axon formation. Mol. Biol. Cell 12, 2087–2098.
Gonzalez-Billault, C., et al. (2005). A role of MAP1B in Reelin-dependent
neuronal migration. Cereb. Cortex 15, 1134–1145.
MAP1B Function in Developing Neurons
Vol. 21, October 15, 2010 3527Gonzalez-Billault, C., Demandt, E., Wandosell, F., Torres, M., Bonaldo, P.,
Stoykova, A., Chowdhury, K., Gruss, P., Avila, J., and Sanchez, M. P. (2000).
Perinatal lethality of microtubule-associated protein 1B-deﬁcient mice ex-
pressing alternative isoforms of the protein at low levels. Mol. Cell Neurosci.
16, 408–421.
Ik-Tsen Heng, J., Chariot, A., and Nguyen, L. (2009). Molecular layers under-
lying cytoskeletal remodelling during cortical development. Cell Press 33(1),
38–47.
Inagaki, N., Chihara, K., Arimura, N., Menager, C., Kawano, Y., Matsuo, N.,
Nishimura, T., Amano, M., and Kaibuchi, K. (2001). CRMP-2 induces axons in
cultured hippocampal neurons. Nat. Neurosci. 4, 781–782.
Kodama, A., Karakesisoglou, I., Wong, E., Vaezi, A., and Fuchs, E. (2003).
ACF7, an essential integrator of microtubule dynamics. Cell 115, 343–354.
Krendel, M., Zenke, F. T., and Bokoch, G. M. (2002). Nucleotide exchange
factor GEF-H1 mediates cross-talk between microtubules and the actin cy-
toskeleton. Nat. Cell Biol. 4, 294–301.
Kunda, P., Paglini, G., Quiroga, S., Kosik, K., and Caceres, A. (2001). Evidence
for the involvement of Tiam1 in axon formation. J. Neurosci. 21, 2361–2372.
Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci.
1, 173–180.
Luo, L. (2002). Actin cytoskeleton regulation in neuronal morphogenesis and
structural plasticity. Annu. Rev. Cell Dev. Biol. 18, 601–635.
Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A.,
Obinata, T., Ohashi, K., Mizuno, K., and Narumiya, S. (1999). Signaling from
Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
Science 285, 895–898.
Meixner, A., Haverkamp, S., Wassle, H., Fuhrer, S., Thalhammer, J., Kropf, N.,
Bittner, R. E., Lassmann, H., Wiche, G., and Propst, F. (2000). MAP1B is
required for axon guidance and Is involved in the development of the central
and peripheral nervous system. J. Cell Biol. 151, 1169–1178.
Nakata, T., and Hirokawa, N. (1987). Cytoskeletal reorganization of human
platelets after stimulation revealed by the quick-freeze deep-etch technique.
J. Cell Biol. 105, 1771–1780.
Ng, J., Nardine, T., Harms, M., Tzu, J., Goldstein, A., Sun, Y., Dietzl, G.,
Dickson, B. J., and Luo, L. (2002). Rac GTPases control axon growth, guidance
and branching. Nature 416, 442–447.
Nishimura, T., Yamaguchi, T., Kato, K., Yoshizawa, M., Nabeshima, Y., Ohno,
S., Hoshino, M., and Kaibuchi, K. (2005). PAR-6-PAR-3 mediates Cdc42-
induced Rac activation through the Rac GEFs STEF/Tiam1. Nat. Cell Biol. 7,
270–277.
Paglini, G., Kunda, P., Quiroga, S., Kosik, K., and Caceres, A. (1998). Sup-
pression of radixin and moesin alters growth cone morphology, motility, and
process formation in primary cultured neurons. J. Cell Biol. 143, 443–455.
Pedrotti, B., and Islam, K. (1996). Dephosphorylated but not phosphorylated
microtubule associated protein MAP1B binds to microﬁlaments. FEBS Lett.
388, 131–133.
Riederer, B. M. (2007). Microtubule-associated protein 1B, a growth-associ-
ated and phosphorylated scaffold protein. Brain Res. Bull. 71, 541–558.
Ruthel, G., and Banker, G. (1999). Role of moving growth cone-like “wave”
structures in the outgrowth of cultured hippocampal axons and dendrites.
J. Neurobiol. 39, 97–106.
Ruthel, G., and Hollenbeck, P. J. (2000). Growth cones are not required for
initial establishment of polarity or differential axon branch growth in cultured
hippocampal neurons. J. Neurosci. 20, 2266–2274.
Sander, E. E., ten Kooster, J. P., van Delft, S., van der Kammen, R. A., and
Collard, J. G. (1999). Rac downregulates Rho activity: reciprocal balance
between both GTPases determines cellular morphology and migratory behav-
ior. J. Cell Biol. 5, 1009–1022.
Sarmiere, P. D., and Bamburg, J. R. (2004). Regulation of the neuronal actin
cytoskeleton by ADF/coﬁlin. J. Neurobiol. 58, 103–117.
Sosa, L., Dupraz, S., Laurino, L., Bollati, F., Bisbal, M., Caceres, A., Pfenninger,
K. H., and Quiroga, S. (2006). IGF-1 receptor is essential for the establishment
of hippocampal neuronal polarity. Nat. Neurosci. 9, 993–995.
Takefuji, M., et al. (2007). Rho-kinase modulates the function of STEF, a Rac
GEF, through its phosphorylation. Biochem. Biophys. Res. Commun. 355,
788–794.
Takei, Y., Kondo, S., Harada, A., Inomata, S., Noda, T., and Hirokawa, N.
(1997). Delayed development of nervous system in mice homozygous for
disrupted microtubule-associated protein 1B (MAP1B) gene. J. Cell Biol. 137,
1615–1626.
Takei, Y., Teng, J., Harada, A., and Hirokawa, N. (2000). Defects in axonal
elongation and neuronal migration in mice with disrupted tau and map1b
genes. J. Cell Biol. 150, 989–1000.
Utreras, E., Jimenez-Mateos, E. M., Contreras-Vallejos, E., Tortosa, E., Perez,
M., Rojas, S., Saragoni, L., Maccioni, R. B., Avila, J., and Gonzalez-Billault, C.
(2008). Microtubule-associated protein 1B interaction with tubulin tyrosine
ligase contributes to the control of microtubule tyrosination. Dev. Neurosci.
30, 200–210.
Watabe-Uchida, M., Keisha, J., Janas Justyna, A., Newey, S. E., and Van Aelst,
L. (2006). The Rac activator Dock7 regulates neuronal polarity through local
phosphorylatin of stathmin/Op18. Neuron 51, 727–739.
Waterman-Storer, C. M., Worthylake, R. A., Liu, B. P., Burridge, K., and
Salmon, E. D. (1999). Microtubule growth activates Rac1 to promote lamelli-
podial protrusion in ﬁbroblasts. Nat. Cell Biol. 1, 45–50.
Witte, H., Neukirchen, D., and Bradke, F. (2008). Microtubule stabilization
speciﬁes initial neuronal polarization. J. Cell Biol. 180, 619–632.
Wittmann, T., and Waterman-Storer, C. M. (2001). Cell motility: can Rho
GTPases and microtubules point the way? J. Cell Sci. 114, 3795–3803.
Wittmann, T., Bokoch, G. M., and Waterman-Storer, C. M. (2004). Regulation
of microtubule destabilizing activity of Op18/stathmin downstream of Rac1.
J. Biol. Chem. 279(7), 6196–6203.
Yang, N., Higuchi, O., Ohashi, K., Nagata, K., Wada, A., Kangawa, K.,
Nishida, E., and Mizuno, K. (1998). Coﬁlin phosphorylation by LIM-kinase 1
and its role in Rac-mediated actin reorganization. Nature 393, 809–812.
C. Montenegro-Venegas et al.
Molecular Biology of the Cell 3528